Key Financial Data Of Group

Modalis Therapeutics Corporation - Filing #7612938

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
As at
2018-12-31
As at
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2017-01-01 to
2017-12-31
As at
2017-12-31
Key financial data of group
Business results of group
Ordinary profit (loss)
-1,277,595,000 JPY
-1,231,299,000 JPY
-439,549,000 JPY
-467,548,000 JPY
146,351,000 JPY
128,822,000 JPY
-213,390,000 JPY
-228,981,000 JPY
-141,200,000 JPY
Profit (loss) attributable to owners of parent
-738,956,000 JPY
-448,407,000 JPY
140,528,000 JPY
-217,909,000 JPY
Comprehensive income
-731,801,000 JPY
-450,325,000 JPY
140,763,000 JPY
-218,101,000 JPY
Net assets
5,446,692,000 JPY
5,549,212,000 JPY
6,165,582,000 JPY
6,206,857,000 JPY
3,842,542,000 JPY
3,819,701,000 JPY
1,191,802,000 JPY
1,201,779,000 JPY
1,421,735,000 JPY
Total assets
5,921,792,000 JPY
6,069,137,000 JPY
6,196,133,000 JPY
6,277,017,000 JPY
3,938,428,000 JPY
3,897,549,000 JPY
1,208,442,000 JPY
1,224,508,000 JPY
1,434,334,000 JPY
Net assets per share
188.03
191.57
216.22
217.67
153.09
152.18
-15.33
-14.84
-389.38
Basic earnings (loss) per share
-27.58
-25.70
-17.02
-17.79
5.96
5.43
-10.84
-11.44
-1,028.95
Diluted earnings per share
Equity-to-asset ratio
0.920 xbrli:pure
0.914 xbrli:pure
0.995 xbrli:pure
0.989 xbrli:pure
0.976 xbrli:pure
0.980 xbrli:pure
0.986 xbrli:pure
0.982 xbrli:pure
0.991 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
0.056 xbrli:pure
0.051 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-747,466,000 JPY
-376,575,000 JPY
224,148,000 JPY
-212,608,000 JPY
Net cash provided by (used in) investing activities
171,563,000 JPY
-830,310,000 JPY
-61,769,000 JPY
-6,996,000 JPY
Net cash provided by (used in) financing activities
72,633,000 JPY
2,777,992,000 JPY
2,490,603,000 JPY
-250,000 JPY
Cash and cash equivalents
4,936,193,000 JPY
5,421,476,000 JPY
3,857,235,000 JPY
1,205,143,000 JPY
Number of employees
3 xbrli:pure
26 xbrli:pure
5 xbrli:pure
3 xbrli:pure
3 xbrli:pure
20 xbrli:pure
16 xbrli:pure
3 xbrli:pure
xbrli:pure
10 xbrli:pure
xbrli:pure
Average number of temporary employees
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
2 xbrli:pure
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.